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Background: Non-adherence to tuberculosis (TB) treatment threatens the success of treatment, increases the risk of
TB spread, and leads to the development of drug resistance. The present study assessed non-adherence to anti-TB
treatment among internal migrants with pulmonary TB living in Shenzhen, China, and examined risk factors for
non-adherence in order to identify targets for intervention.
Methods: A total of 794 internal migrants with TB treated at Bao’an Hospital for Chronic Disease Prevention and
Cure, Shenzhen, were recruited. Structured questionnaires were used to collect data on these patients’ history and
experiences with TB treatment. Ordinal logistic regression model were used to identify risk factors for non-adherence.
Results: The proportion of patients who had missed one dose of medication within two weeks was 93/794 (11.71%),
and those who missed at least two doses of medication within two weeks was 167/794 (21.03%), with a total of
33.74% of patients not adhering to TB treatment. Lack of knowledge about TB treatment and longer travel time to the
nearest community health centers are significant predictors for non-adherence.
Conclusions: The present study shows that non-adherence is common among internal migrants with TB. Patients who
lack knowledge about TB treatment or have to travel far to get treated are prone to miss one or more doses of
medication. Interventions to improve health education and healthcare access are essential to reduce non-adherence to
TB treatment among internal migrants.
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Tuberculosis (TB) remains a major global health prob-
lem. According to the World Health Organization
(WHO), there were 8.6 million new cases of TB and 1.3
million died from this disease worldwide in 2012 [1].
China accounted for 12% of total TB cases worldwide
[1]. Data from the Fifth National TB Epidemiological
Survey in 2010 showed that there were about 4.99 mil-
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unless otherwise stated.active pulmonary TB of 459/100,000, and a prevalence
rate of sputum smear positive TB of 66/100,000 [2].
Besides active surveillance and prevention, treatment
adherence is of the greatest importance in TB control. A
standard anti-TB treatment requires the use of a number
of medications regularly for a period of at least 6 months
for a new patient and 8 months for a retreatment pa-
tient, which has been implemented in programs such as
Directly Observed Therapy, Short-course (DOTS), pro-
moted vigorously by WHO [3]. Many factors from pa-
tient activation to care access can come into play and
undermine the treatment adherence, threatening the
success of treatment, increasing morbidity and mortality,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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spread [4].
TB treatment adherence is especially problematic
among China’s internal migrants, those who live or work
outside their counties of origin for extended periods.
Previous studies suggest that internal migrants suffer a
disproportionate burden of TB in China [5,6]. The propor-
tion of cases cured among permanent residents was
90.6%, compared with only 37.0% of cases among internal
migrants [5]. These internal migrants, now numbering
about 236 million nationwide, are mostly young adults
who have relocated from poor rural areas to seek a better
livelihood in cities [7]; they tend to live and work in
crowded environments, far from their families and com-
munities, poor, with limited education, and are less likely
to seek medical care when they become ill [8]. For these
reasons, internal migrants face much greater challenges in
TB treatment adherence than permanent residents do.
This study intended to explore non-adherence in TB
treatment among internal migrants with TB in the city
of Shenzhen. A highly mobile, dynamic city that spear-
headed China’s market capitalism reform, Shenzhen has
seen its population growing from 12 thousand in 1980
to 7.7 million in 2012 [9], with internal migrants ac-
counting for more than 70% of the population [9]. By
interviewing a sample of TB patients living in Bao’an
District, the largest district of Shenzhen, we examined
risk factors for non-adherence to TB treatment in order
to identify targets for intervention.
Methods
The study protocol was approved by the Research Ethics
Committee of Huazhong University of Science and
Technology, Wuhan, China. All the participants read the
purpose statement of the investigation and each pro-
vided a written informed consent.
Setting and study population
Tuberculosis services in Bao’an District are provided
through a vertical system consisting of the TB depart-
ments at the Bao’an District Hospital for Chronic Dis-
eases Prevention and Cure (BHCDPC), subdistrict
institutions for disease prevention and healthcare, and
community health centers (CHCs). Central to China’s
TB control endeavor, all health care providers, includ-
ing public health facilities, hospitals and clinics, are re-
quired to refer suspected TB cases to BHCDPC for TB
diagnosis and treatment. Subdistrict institutions and
CHCs collaborate with BHCDPC to manage patients
and ensure patients adherence. All confirmed TB cases
are required to undergo a standard anti-TB treatment.
Anti-TB fix-dose combination (FDC) products are pro-
vided to TB patients free of charge. During the 2-
month intensive phase and the subsequent continuationphase of treatment, all TB patients are required to visit
the CHCs every day to take medicines. Doctors at the
CHCs are responsible for asking patients for their ad-
verse drug reactions and contacting patients regularly
to ensure they complete their treatment.
This cross-sectional study was conducted at BHCDPC,
the only authorized institution providing TB diag-
nosis and treatment services for TB patients in Bao’an
District. The participants of this study met the following
criteria: 1) active pulmonary TB patients registered at
BHCDPC and visited it between December 2013 and
March 2014; 2) patients who were taking anti-TB medi-
cations and had taken them for over half a month; 3) mi-
grant population, i.e. those who had resided in Shenzhen
for >3 months but whose hukou (household registration)
were still held in their homelands but not in Shenzhen;
and 4) patients who were willing to participant in the
study. During this period, 794 migrant TB patients were
enrolled and completed a structural self-administered
questionnaire.
Assessment of TB treatment Non-adherence
The questionnaire was developed based on a review of
previous literature and was tested in a pilot study with
15 TB patients to ensure that the questions were clear
and understandable to all participants. The question-
naire included five sections: socio-demographic charac-
teristics (gender, age, educational level, marital status,
and employment status); social support; knowledge and
attitude towards anti-TB treatment; travel time from
home to the nearest CHC; and adherence to anti-TB
treatment. In addition, patients’ clinical characteristics
including the history of prior anti-TB treatment and
sputum smear status were extracted from China’s Na-
tional TB Information Management System (TBIMS), an
internet-based TB case report and management system.
We used an open-ended question to define non-
adherence to TB treatment: “Over the past two weeks,
how many doses of anti-TB medication did you miss?”
Patients who had missed at least one prescribed dose of
TB drug were deemed as non-adherence.
Social support for patient was assessed by the Social
Support Rating Scale (SSRS) [10], which has been widely
used in studies of Chinese populations, demonstrating
high reliability and validity and high internal consis-
tency [11,12]. The SSRS has ten items to evaluate total
social support, including three items for levels of objec-
tive support, four items for subjective support, and
three items for the utility of support. The total score is
used as a measure of the current total social support
status, ranging from 12 (worst possible social support)
to 66 (best possible social support). The score was
divided into three categories based on its mean and
standard deviation in our analysis.
Table 1 Participant characteristics and their associations
with missing doses of anti-TB medication within two
weeks
Missed doses in two
weeks (%)
Variables n (%) 0 1 2+ P
Total 794 67.25 11.71 21.03
Age 0.47
<25 202 (25.44) 65.35 10.40 24.26
25~ 318 (40.05) 65.09 14.78 20.13
35~ 164 (20.65) 73.17 8.54 18.29
45~ 67 (8.44) 71.64 5.97 22.39
55~ 43 (5.42) 62.79 16.28 20.93
Gender 0.97
Female 284 (35.77) 66.90 12.68 20.42
Male 510 (64.23) 67.45 11.18 21.37
Educational level 0.02
Primary school or less 69 (8.69) 72.46 11.59 15.94
Junior high school 378 (47.61) 71.16 10.85 17.99
Senior high school 232 (29.22) 59.91 12.07 28.02
Junior college or above 115 (14.48) 66.09 13.91 20.00
Marital status 0.04
Married/cohabitation 483 (60.83) 69.57 12.42 18.01
Single/widow/divorced 311 (39.17) 63.67 10.61 25.72
Employment status 0.02
Employed 580 (73.05) 65.00 12.24 22.76
Unemployed 214 (26.95) 73.36 10.28 16.36
Social support 0.06
Good 135 (17.00) 68.89 11.85 19.26
Fair 530 (66.75) 65.09 11.32 23.58
Poor 129 (16.25) 74.42 13.18 12.40
History of prior anti-TB treatment 0.06
New case 718 (90.43) 66.30 11.84 21.87
Retreated case 76 (9.57) 76.32 10.53 13.16
Sputum smear status 0.15
Positive 449 (56.55) 69.27 11.36 19.38
Negative 345 (43.45) 64.64 12.17 23.19
Travel time to the nearest CHC 0.04
<15 Mins 456 (57.43) 69.52 13.38 17.11
≥15 Mins 338 (42.57) 64.20 9.47 26.33
Can TB patients stop anti-TB treatment by themselves
when mild adverse drug reaction appears?
0.0013
No, they cannot. 412 (51.89) 71.84 13.59 14.56
Yes, they can. 170 (24.41) 59.41 11.76 28.82
Not sure 212 (26.70) 64.62 8.02 27.36
It does not matter that TB patients miss some doses of
anti-TB medication, does it?
0.0027
Table 1 Participant characteristics and their associations
with missing doses of anti-TB medication within two
weeks (Continued)
Yes, it does. 652 (82.12) 69.79 11.35 18.87
No, it does not. 48 (6.05) 56.25 16.67 27.08
Unknown. 94 (11.84) 55.32 11.70 32.98
Does TB patient need to keep anti-TB treatment up when
symptoms disappear?
0.52
Yes. 438 (55.16) 68.26 12.10 19.63
No. 95 (11.96) 67.37 16.84 15.79
Unknown. 261 (32.87) 65.52 9.20 25.29
Note: P values are associated with rank-sum tests.
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treatment was measured by three questions: 1) “Can TB
patients stop anti-TB treatment by themselves when
mild adverse drug reactions appear?” 2) “It does not
matter that a TB patients misses some doses of anti-TB
medication, doesn’t it?” and 3) “Does a TB patient need
to keep anti-TB treatment up when symptoms dis-
appear?” All these questions have three optional an-
swers: yes, no or do not know.
Statistical analysis
The data were double-entered into EpiData 3.0 for Win-
dows (EpiData Association, Odense, Denmark) by two
individuals separately. All statistical procedures were
performed using the Statistical Analysis System (SAS)
9.2 for Windows (SAS Institute Inc., Cary, NC, USA).
Rank-sum tests were conducted to compare missing
doses of anti-TB medication within two weeks across
groups defined by socio-demographic data, social support,
travel time to the nearest CHC, clinical characteristics,
and knowledge and attitude towards anti-TB treatment.
Ordinal logistic regression analysis was used to analyze
the potential risk factors of non-adherence. All compar-
isons were two-tailed. The significance threshold was
set at p = 0.05.
Results
Table 1 presents the rates of non-adherence to TB treat-
ment by participants characteristics. The age of the pa-
tients ranged from 14 to 84 years old, with mean age of
32.57 (standard deviation (SD): 10.93) years. Overall,
33.74% of the patients were considered non-adherent.
The proportion of patients who had missed one dose
and more than one dose of medication within two weeks
were 11.71% and 21.03%. Patients with lower education
level, single, employed, newly diagnosed, living farther
away from CHC had higher rates of non-adherence, and
their lack of knowledge about anti-TB treatment was
also associated with higher non-adherence rates. Table 2
shows that, among the reasons queried, forgetfulness
Table 2 Reasons of missing doses of anti-TB medication
Missing doses in two weeks Total
1 (N = 93) 2 + (N = 167)
n % n % n %
To avoid side effects. 2 2.15 9 5.39 11 4.23
Too busy. 41 44.09 109 65.27 150 57.69
Forgetfulness. 44 47.31 124 74.25 168 64.62
Anti-TB pills have been run out. 32 34.41 76 45.51 108 41.54
Worrying that somebody may despise me. 2 2.15 4 2.4 6 2.31
Confusing about the dose of anti-TB medicines. 0 0 1 0.6 1 0.38
Travelling to other places. 14 15.05 32 19.16 46 17.69
Others 6 6.45 7 4.19 13 5
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pills (41.54%), were the most frequently cited for missing
the anti-TB pills (Table 2).
Table 3 presents the results from the ordinal logistic
regression model. Controlling for confounding, TB pa-
tients who needed 15 minutes or more time to travel
from home to the nearest CHC were more likely to miss
doses of anti-TB medication than those who took less
than 15 minutes (OR = 1.41). Participants who believed
or were not sure that TB patients could stop anti-TB
treatment by themselves when mild adverse drug reac-
tions appear were more likely to miss doses of medica-
tion than those who believed otherwise (OR = 1.58). The
respondents who did not consider or were not sure that
it did matter that TB patients miss some doses of anti-
TB medication had higher odds for missing doses of
medication (OR = 1.89).
Discussion
The present study demonstrated that non-adherence
was common among internal migrants in China. Some
previous studies in China also indicated low treatment
adherence among TB patients [13,14]. A study recruited
524 TB patients in mountain areas indicated that 9.4%
of patients took less than 90% of all doses prescribed
[15]. Hu et al. reported that 12.5% of patients had not
taken any TB drugs in the previous week [14]. Another
study conducted in Jiangsu Province in China reported
that 12.2% of patients missed at least 10% of their pre-
scribed doses of anti-TB medication [16]. A recent study
in Shandong Province in China found that 16% of mi-
grant TB patients did not adherent to TB therapy [13].
The proportion of non-adherence in our study is higher
than that were reported in previous studies, and much
of the difference may be due to differences in study design
and definition of non-adherence to anti-TB treatment. In
our study, we employed TB patient’s self-reported drug-
taking history within two weeks before the interview,
which could have in some extent reduced recall bias.Another frequently used definition of non-adherence is
the WHO recommended measure, which defines a TB
treatment defaulter as a patient who interrupted treatment
for two consecutive months or more [17]. Furthermore, a
few studies considered a patient who had missed 10% or
more of the total prescribed doses of TB drugs as non-
adherent [15,16]. Regardless, our estimate is consistent
with previous studies to indicate that non-adherence is a
serious problem among migrant TB patients.
Our study shows that, among the migrant TB patients,
lack of knowledge about TB treatment and longer travel
time to the nearest CHC were the most significant fac-
tors predicting non-adherence, consistent with earlier
studies. Driver et al. explored the determinants for treat-
ment interruption and indicated that lack of TB and its
treatment related knowledge were important reasons for
discontinuing treatment [18]. Many studies have illus-
trated a positive effect of health education on improving
treatment adherence. A cluster randomized trial in
Senegal showed that intensive strategy of treatment
monitoring and education led to improved adherence to
medications and improved outcomes among TB patients
[19]. In fact, the National TB Control Program Imple-
mentation Guide in China (2008 Edition) states clearly
that carrying out health education for TB patients before
chemotherapy was the most important step of DOTS
implementation, and the treatment regimen and import-
ance of adherence were the core of health education. In
our study site, doctors implement health education for
all TB patients before chemotherapy. However, some
participants were still confused about treatment regimen
after health education, indicating the need for improve-
ment in the health education segment of the program.
Our study indicated that, after controlling for patient
knowledge on TB treatment and travel time to the near-
est CHCs, non-adherence to anti-TB treatment was not
associated with migrant TB patients’ socio-demographic
characteristics such as gender, age, educational level,
marital status and employment status. The associations
Table 3 Ordinal logistic regression analysis of missing
any dose of anti-TB medication in two weeks with
mutually adjusted ORs and 95% CI
OR (95% CI) P
Age (Ref§: <25)
25~ 1.12 (0.74-1.69) 0.59
35~ 0.94 (0.55-1.59) 0.81
45~ 1.12 (0.57-2.21) 0.75
55~ 1.50 (0.70-3.21) 0.30
Gender (Ref: Female)
Male 0.92 (0.66-1.28) 0.61
Educational level (Ref: Primary
school or less)
Junior high school 1.10 (0.60-2.02) 0.75
Senior high school 1.77 (0.93-3.36) 0.08
Junior college or above 1.28 (0.62-2.62) 0.50
Marital status
(Ref: Married/cohabitation)
Single/widow/divorced 1.24 (0.85-1.80) 0.27
Employment status
(Ref: Employed)
Unemployed 0.68 (0.47-0.98) 0.04
Social support
(Ref: good)
Fair 1.09 (0.71-1.67) 0.68
Poor 0.66 (0.37-1.17) 0.15
History of prior anti-TB treatment
(Ref: New case)
Retreated case 0.61 (0.34-1.09) 0.09
Sputum smear status (Ref: Positive)
Negative 1.09 (0.80-1.49) 0.59
Travel time to the nearest CHC
(Ref: <15Mins)
≥15 Mins 1.41 (1.04-1.92) 0.03
Can TB patients stop anti-TB
treatment by themselves when
mild adverse drug reaction
appears? (Ref: No, they cannot.)
Yes, they can./Not sure. 1.58 (1.16-2.15) <0.01
It does not matter that TB patients
miss some doses of anti-TB
medication, does it? (Ref: Yes,
it does.)
No, it does not./Unknown. 1.89 (1.30-2.74) <0.01
Does TB patient need to keep anti-TB
treatment up when symptoms disappear?
(Ref: Yes.)
No./Unknown. 0.99 (0.73-1.35) 0.96
§Ref is reference.
Tang et al. BMC Public Health  (2015) 15:474 Page 5 of 6between non-adherence and demographic characteristics
have been explored in many studies and their results are
inconsistent [20–22]. For example, marital status isreported to be associated with adherence to anti-TB
treatment [13]; some researchers believed that family
members, especially the spouse, played an important
role in treatment supervision. However, participants in
our study needed to take anti-TB medication in health-
care facilities every day, and the supervision of their
family members was not indispensable. Furthermore, of
the internal migrants, many married people lived separ-
ately from their spouses. Another of our findings that
seem inconsistent with previous studies is on the associ-
ation between social support and adherence [22]. It is
worth noting that social support is relatively poor in all
migrant TB patients, and our social support measure
using SSRS might not have meaningfully distinguish
those with strong versus weak social support.
Several limitations of this study need to be stated.
Firstly, the treatment adherence levels were based on
self-reported information from patients, so recall bias
was unavoidable. Secondly, the occurrence of adverse
drug reactions of taking anti-TB medications, which is a
determinant of the non-adherence, was not taken into
consideration in our analysis.
Conclusion
Our study indicates that non-adherence among migrant
pulmonary TB patients is common and patients’ know-
ledge about anti-TB treatment is crucial to improve mi-
grant pulmonary TB patients’ treatment adherence. In
the TB treatment program, health care providers should
assure that all patients understand the core knowledge
of anti-TB treatment regimen and the importance of ad-
herence. In addition, efforts in improving the migrant
TB patients’ general access to care may also help them
to complete TB treatment.
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